Literature DB >> 7202121

Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide.

C Pollick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7202121     DOI： 10.1056/NEJM198210143071607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.

Authors:  K Niki; M Sugawara; S Tanino; K Iwade; S Hosoda; H Kasanuki
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Medical treatment of hypertrophic cardiomyopathy.

Authors:  M V Sherrid; D Gunsburg; A Sharma
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

3.  Hypertrophic Cardiomyopathy.

Authors:  Elijah R. Behr; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

4.  General Anesthetic Management of a Patient With Hypertrophic Cardiomyopathy for Oral Surgery: Did Digitalis Contribute to Bradycardia?

Authors:  Aiji Sato Boku; Maki Morita; MinHye So; Tetsuya Tamura; Fumiaki Sano; Yasuyuki Shibuya; Jun Harada; Kazuya Sobue
Journal:  Anesth Prog       Date:  2018

Review 5.  Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.

Authors:  Daniel L Jacoby; Eugene C DePasquale; William J McKenna
Journal:  CMAJ       Date:  2012-10-29       Impact factor: 8.262

6.  The efficacy of cibenzoline for reducing the left ventricular pressure gradient of hypertrophic obstructive cardiomyopathy: A case report.

Authors:  Hideki Igarashi
Journal:  J Med Ultrason (2001)       Date:  2003-06       Impact factor: 1.314

7.  Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Tai Sekine; Masao Daimon; Rei Hasegawa; Kiyomi Teramoto; Takayuki Kawata; Nobuhiro Tanaka; Yasuhiro Takei; Kenji Takazawa; Katsuya Yoshida; Issei Komuro
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

Review 8.  Management of hypertrophic cardiomyopathy in children.

Authors:  Hubert Seggewiss; Angelos Rigopoulos
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

10.  Effect of disopyramide on left ventricular diastolic function in patients with hypertrophic cardiomyopathy: comparison with diltiazem.

Authors:  T Sumimoto; M Hamada; T Ohtani; M Suzuki; M Abe; H Matsuoka; Y Fujiwara; M Sekiya; K Hiwada
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.